Skip to content

Construction and Evaluation of an Intervention Protocol for Post-TACE Depression Syndrome in Hepatocellular Carcinoma Patients

Construction and Evaluation of an Intervention Protocol for Post-TACE Depression Syndrome in Hepatocellular Carcinoma Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114319
Enrollment
Unknown
Registered
2025-12-10
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

control group:Routine nursing care after TACE for liver cancer includes providing psychological support, health education, pain assessment, medication guidance, and daily activity guidance to patients
intervention group:On the basis of routine nursing, a nursing intervention combining mindfulness cancer rehabilitation training and pentatonic therapy is implemented, with a frequency of 8 days. Each

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: 1. For patients diagnosed with primary liver cancer, the diagnostic criteria for liver cancer are based on the European Association for the Study of the Liver (EASL) criteria, including pathological diagnosis, at least two different imaging techniques detecting positive lesions, and imaging techniques combined with alpha fetoprotein>400ng/ml; 2. Age >= 18 years old; 3. Child Pugh's liver function classification is A or B; 4. Accept hepatic artery chemoembolization (TACE); 5. Voluntarily participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Accompanied by other serious physical illnesses and hearing impairments; 2. Consciousness disorders or a history of mental illness; 3. Lack of language proficiency to independently complete scale assessments; 4. Participated in other clinical trial studies in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Obsessive Compulsive Syndrome Scale II;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index, PSQI;Psychological Resilience Scale;SF-12 Survey Form;

Countries

China

Contacts

Public ContactLian Xiaojing

Beijing Youan Hospital, Capital Medical University

lxj2682@163.com+86 187 0131 5038

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026